Literature DB >> 15048646

Association between the glutathione S-transferase M1 gene deletion and female methamphetamine abusers.

Hiroki Koizumi1, Kenji Hashimoto, Chikara Kumakiri, Eiji Shimizu, Yoshimoto Sekine, Norio Ozaki, Toshiya Inada, Mutsuo Harano, Tokutaro Komiyama, Mitsuhiko Yamada, Ichiro Sora, Hiroshi Ujike, Nori Takei, Masaomi Iyo.   

Abstract

Several lines of evidence suggest that increased generation of auto-oxidized dopamine (DA) o-quinone is associated with the neurotoxicity of methamphetamine (MAP) in the brain, and that, as a cellular defenses against DA-derived quinines, glutathione S-transferase (GST) detoxifies auto-oxidized DA o-quinone in the brain. Glutathione S-transferase M1 (GSTM1) of the mu-class of GSTs catalyzes reaction between glutathione and catecholamine o-quinones under physiological conditions. This study was undertaken to investigate the role of the GSTM1 gene deletion polymorphism in the neuropathology of MAP abuse. One hundred fifty-seven MAP abusers and 200 healthy comparison subjects were tested for a genetic polymorphism of GSTM1. The difference in the frequency of deletion (D)/non-deletion (N) alleles between the female abusers and female controls was close to statistical significance (P = 0.071), although there was no statistical difference (P = 0.651) between male abusers and male controls. Furthermore, the number of female abusers with deletion alleles was significantly (P = 0.007, odds ratio: 2.77, 95% CI 1.30-5.89) higher than that of male abusers with deletion alleles. These findings suggest that GSTM1 gene deletion may contribute to a vulnerability to MAP abuse in female subjects, but not in male subjects. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048646     DOI: 10.1002/ajmg.b.20148

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  13 in total

Review 1.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

2.  No association between GSTM1 and GSTT1 genetic polymorphisms and susceptibility to opium sap dependence.

Authors:  Khyber Saify; Mohammad Rashid Khalighinasab; Mostafa Saadat
Journal:  Mol Biol Res Commun       Date:  2016-03

3.  Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes.

Authors:  Shabnam Nohesara; Mohammad Ghadirivasfi; Mahmood Barati; Mohammad-Reza Ghasemzadeh; Samira Narimani; Zohreh Mousavi-Behbahani; Mohammadtaghi Joghataei; Mansoureh Soleimani; Mozhgan Taban; Soraya Mehrabi; Sam Thiagalingam; Hamid Mostafavi Abdolmaleky
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-10-18       Impact factor: 3.568

Review 4.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 5.  r

Authors:  Jacqueline S Womersley; Danyelle M Townsend; Peter W Kalivas; Joachim D Uys
Journal:  Eur J Neurosci       Date:  2018-09-24       Impact factor: 3.386

Review 6.  Biological treatments for amfetamine dependence : recent progress.

Authors:  Kevin P Hill; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  No Association Between AKT1 Polymorphisms and Methamphetamine Addiction in Iranian Population.

Authors:  Soudeh Ghafouri-Fard; Iman Azari; Fatemeh Hashemian; Azim Nejatizadeh; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2019-10-25       Impact factor: 3.444

8.  The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population.

Authors:  Hideaki Kobayashi; Hiroshi Ujike; Nakao Iwata; Toshiya Inada; Mitsuhiko Yamada; Yoshimoto Sekine; Naohisa Uchimura; Masaomi Iyo; Norio Ozaki; Masanari Itokawa; Ichiro Sora
Journal:  Behav Brain Funct       Date:  2010-08-30       Impact factor: 3.759

Review 9.  Methamphetamine-associated psychosis.

Authors:  Kathleen M Grant; Tricia D LeVan; Sandra M Wells; Ming Li; Scott F Stoltenberg; Howard E Gendelman; Gustavo Carlo; Rick A Bevins
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

Review 10.  Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Authors:  Alexandre A Guerin; Eric J Nestler; Michael Berk; Andrew J Lawrence; Susan L Rossell; Jee Hyun Kim
Journal:  Neurosci Biobehav Rev       Date:  2020-11-17       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.